stephen silberstein, md, director, jefferson university headache center..
on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation......
marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".